2BBBullish & Bearish
Vertex Pharmaceuticals Incorporated (VRTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 63 out of 100.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Vertex Pharmaceuticals Incorporated’s current 2BB score is 63 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 66 | High |
| Momentum | 50 | Stable |
| Financial strength | 86 | Very Strong |
| Quality | 98 | Very Strong |
| Risk | 8 | Very Low |
| CEO | Reshma Kewalramani |
| Headquarters | Boston, Massachusetts, United States |
| Founded | 1989 |
| Employees | 6.4K |
| P/E ratio | 29.01 |
| 52-week range | $403.16 – $560.25 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | 4.8511 | — | $3.58B |
| 2026-11-02 | — | 4.8917 | — | $3.48B |
| 2026-08-03 | 4.73 | 4.8241 | $3.33B | $3.30B |
| 2026-05-04 | 4.47 | 4.3964 | $2.99B | $3.08B |